The National Marrow Donor Program
Showing 1 - 25 of >10,000
Samples and Data for National Marrow Donor Program Repository
Recruiting
- Bone Marrow Transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 1, 2022
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,
Recruiting
- Primary T-cell Immunodeficiency Disorders
- +4 more
- Immunosuppression Only Conditioning -Closed with amendment L
- +4 more
-
Bethesda, Maryland
- +1 more
Jul 26, 2022
Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022
AML Patients After Stem Cell Transplant to Understand Relapse
Recruiting
- Acute Myeloid Leukemia in Remission
- Prospective determination of the clinical utility of measurable residual disease (MRD) testing
-
Duarte, California
- +3 more
Dec 7, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Allogeneic Hematopoietic Cell Transplantation in Medicare
Recruiting
- Multiple Myeloma
- Allogeneic Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in United States (Best Practice and Internet site with links to existing resources,
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Best Practice and Internet site with links to existing resources
- +2 more
-
Tampa, Florida
- +14 more
Dec 5, 2022
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
National Marrow Donor Program Long-Term Donor Follow-Up
Completed
- Hematologic Neoplasms
-
Duarte, California
- +28 more
Oct 19, 2020
Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,
Terminated
- Related Donors Donating PBSC to a Family Member
- +4 more
- MGTA-145
- Plerixafor
-
Duarte, California
- +7 more
Apr 13, 2022
Improve the Informed Consent Process Trial in United States (Consent Form Specific Format 1, Consent Form Specific Format 2)
Completed
- Improve the Informed Consent Process
- Consent Form Specific Format 1
- Consent Form Specific Format 2
-
Duarte, California
- +22 more
Dec 6, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Hematopoietic Stem Cell Transplant
-
Birmingham, Alabama
- +21 more
Dec 6, 2022
Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)
Completed
- Multiple Myeloma
- Allogeneic HSCT
- +5 more
-
Birmingham, Alabama
- +14 more
Jan 25, 2022
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Pneumonia, Idiopathic Pneumonia Syndrome Trial in United States (Etanercept, Placebo plus corticosteroid)
Completed
- Pneumonia
- Idiopathic Pneumonia Syndrome
- Etanercept
- Placebo plus corticosteroid
-
Gainesville, Florida
- +11 more
Oct 21, 2021